Oxazepam is a Oral Capsule, Gelatin Coated in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Oxazepam.
Product ID | 0228-2073_15e9b5a9-c45d-4d21-adb5-57194d152fbd |
NDC | 0228-2073 |
Product Type | Human Prescription Drug |
Proprietary Name | Oxazepam |
Generic Name | Oxazepam |
Dosage Form | Capsule, Gelatin Coated |
Route of Administration | ORAL |
Marketing Start Date | 2007-01-02 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA072253 |
Labeler Name | Actavis Pharma, Inc. |
Substance Name | OXAZEPAM |
Active Ingredient Strength | 30 mg/1 |
Pharm Classes | Benzodiazepine [EPC],Benzodiazepines [CS] |
DEA Schedule | CIV |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2007-01-02 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA072253 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2007-01-02 |
Marketing Category | ANDA |
Application Number | ANDA072253 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2007-01-02 |
Marketing End Date | 2012-04-10 |
Ingredient | Strength |
---|---|
OXAZEPAM | 30 mg/1 |
SPL SET ID: | a0d5a4c1-ec79-42e6-8e8f-ae4d144edb43 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0228-2067 | Oxazepam | Oxazepam |
0228-2069 | Oxazepam | Oxazepam |
0228-2073 | Oxazepam | Oxazepam |
0781-2809 | Oxazepam | Oxazepam |
0781-2810 | Oxazepam | Oxazepam |
0781-2811 | Oxazepam | Oxazepam |
43353-074 | Oxazepam | Oxazepam |
43353-965 | Oxazepam | Oxazepam |
43353-980 | Oxazepam | Oxazepam |
52817-290 | Oxazepam | Oxazepam |
52817-291 | Oxazepam | Oxazepam |
52817-292 | Oxazepam | Oxazepam |
62584-812 | Oxazepam | Oxazepam |
62584-813 | Oxazepam | Oxazepam |
62584-814 | Oxazepam | Oxazepam |
67544-294 | Oxazepam | Oxazepam |
67544-117 | Oxazepam | Oxazepam |
67544-268 | Oxazepam | Oxazepam |